title: Epidemiological and clinical profile of patients with chronic myeloid leukemia at Health-Care Global, Bangalore Institute of Oncology.
abstract: Health-Care Global, Bangalore Institute of Oncology is a cancer care center, which provides comprehensive care for cancer patients. Here, we present data of 350 patients diagnosed as cases of chronic myeloid leukemia over a period of 10 years. In our patient population, there was male predominance and majority of patients lied between the age group of 40 and 50 years. 90% patients were initially started on 400 mg dose of imatinib. About 30% of patient population required dose excalation due to inadequate response while 10% required dose descalation due to myelosuppression. 60% of patients had complete response by 3 months and 52% of patients had major molecular response by 1 year.
authors: Department of Medical Oncology, Health-Care Global, Bangalore Institute of Oncology, Bengaluru, Karnataka, India.
authors: K G
authors: KG
authors: Srinivas
authors: Department of Medical Oncology, Health-Care Global, Bangalore Institute of Oncology, Bengaluru, Karnataka, India.
authors: Shekar
authors: S
authors: Patil
authors: Department of Medical Oncology, Health-Care Global, Bangalore Institute of Oncology, Bengaluru, Karnataka, India.
authors: Shashidhara
keywords: Bangalore; chronic myeloid leukemia; chronic phase